FDA advises on drug naming; Novavax seeks new flu vax partner for Spain;

> New FDA guidance advises drugmakers on the creation of proprietary drug names to minimize medication errors. Guidance

> Novavax has discontinued its deal with ROVI Pharmaceuticals to develop the former's influenza vaccine for Spain. Release

> As the camera film business continues its decline, Kodak is using its manufacturing operations and expertise to produce gels for the pharma industry as well as inks and dyes for personal-care products. Article

> Regis Technologies of Morton Grove, IL, has passed the FDA's pre-approval inspection for its manufacture of the active ingredient in multiple sclerosis drug Ampyra, approved last month. Release

> Sweden's Medical Products Agency is proposing that an environmental certification for pharmaceutical production facilities be introduced into Good Manufacturing Practice requirements. Article